Dr. Ozols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 215-728-6900- Is this information wrong?
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1974 - 1976
- University of Rochester School of Medicine and DentistryClass of 1974
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2008
- Elected Member The American Society for Clinical Investigation, 1988
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 13 citationsDifferences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.Katherine Fuh, James J. Java, John K. Chan, Daniel S. Kapp, Bradley J. Monk, Robert A. Burger, Robert C. Young, William P. McGuire, Maurie Markman, Jeffrey G. Bell, Ro...> ;Gynecologic Oncology. 2019 Aug 1
- Counterpoint: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer? There Is No Role for IP Chemotherapy in Ovarian CancerRobert F Ozols> ;Oncology. 2018 Feb 15
- 106 citationsReclassification of serous ovarian carcinoma by a 2-tier system: A Gynecologic Oncology Group studyDiane C. Bodurka, Michael T. Deavers, Chunqiao Tian, Charlotte C. Sun, Anais Malpica, Robert L. Coleman, Karen H. Lu, Anil K. Sood, Michael J. Birrer, Robert F. Ozols,...> ;Cancer. 2012 Jun 15
- Join now to see all
Grant Support
- Spore In Ovarian CancerNational Cancer Institute1999–2006
- Core--BiostatisticsNational Cancer Institute1999–2002
- Phase I Clinical Trials Of Anticancer AgentsNational Cancer Institute1995–1997
- Reversal Of Drug Resistance In Ovarian CancerNational Cancer Institute1990–1997
- Detection &Reversal Of Ovarian Cancer Drug ResistanceNational Cancer Institute1990–1992
- Symposium On The Biology &Therapy Of Ovarian CancerNational Cancer Institute1990
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: